Urovant Sciences Ltd
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Urovant Sciences Ltd generated cash of -$102,084,000, which is more than the previous year. Cash used in financing activities reached the amount of $68,937,000 last year. Net change in cash is therefore -$33,916,000.

Cash Flow

Urovant Sciences Ltd (NASDAQ:UROV): Cash Flow
2017 -25.25M 0 30.02M
2018 -34.08M -521.98K 37.03M
2019 -109.03M -593K 188.63M
2020 -102.08M -769K 68.93M

UROV Cash Flow Statement (2017 – 2020)

2020 2019 2018 2017
Cash at beginning of period
85.35M7.19M4.76M0
Operating activities
Net income
-146.74M-111.34M-37.07M-26.97M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
246K180K12.41K0
Stock-based compensation expense
20.48M3.97M3.17M880.43K
Deferred income tax benefit 20.48M3.97M3.17M880.43K
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
-336K1.09M816.85K15.94K
Cash generated by operating activities
-102.08M-109.03M-34.08M-25.25M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-769K-593K-521.98K0
Acquisitions Net
0000
Cash generated by investing activities
-769K-593K-521.98K0
Financing activities
Common Stock Issued
1.4M132.93M00
Payments for dividends
0000
Repurchases of common stock
1.04M41.63M00
Repayments of term debt
-47.85M000
Cash used in financing activities
68.93M188.63M37.03M30.02M
Net Change In Cash
-33.91M79.00M2.42M4.76M
Cash at end of period
51.43M86.19M7.19M4.76M
Data sourceData source